产品名称 Erastin
产品货号 Axon 1825 CAS [571203-78-6] MF C30H31ClN4O4MW 547.04 Purity: 99% Soluble in DMSO Description An anti-tumor agent with RAS-selective lethality. Erastin binds to mitochondrial voltage-dependent anion channels (VDAC) proteins, more specifically on VDAC2 and alters its gating; induce non-apoptotic cell death selectively in some tumour cells harbouring activating mutations in the RAS-RAF-MEK pathway References Certificates Categories Extra info N Yagoda et al. RAS–RAF–MEK-dependent oxidative cell death involving voltage-dependent anion channels. Nature 2007, 447, 865-869.    Citation: JF Foley, Selective Killing. Sci. STKE 2007, 391, p. tw212.    E imamura et al. Mitochondrial voltage-dependent anion channels (VDACs) as novel pharmacological targets for anti-cancer agents. J. Bioenerg. Biomembr. 2008, 40(3), 213-217.  Certificate of Analysis Material Safety Data Sheet Apoptosis Cell Cycle Regulation Cell Signaling & Oncology VDAC2 Unclassified VDAC2 modulator Chemical name 4(3H)-Quinazolinone, 2-[1-[4-[2-(4-chlorophenoxy)acetyl]-1-piperazinyl]ethyl]-3-(2-ethoxyphenyl)- Parent CAS No. [571203-78-6] Order Size Unit Price Stock 5 mg €95.00 In Stock
产品价格 现货询价,电话:010-67529703
产品规格
产品品牌 axonmedchem
产品概述
产品详情

Erastin

Based on 8 reference(s) in Google Scholar 9 10 8

Axon 1825

CAS [571203-78-6]

MF C30H31ClN4O4
MW 547.04

  • Purity: 99%
  • Soluble in DMSO

Erastin

Description

An anti-tumor agent with RAS-selective lethality. Erastin binds to mitochondrial voltage-dependent anion channels (VDAC) proteins, more specifically on VDAC2 and alters its gating; induce non-apoptotic cell death selectively in some tumour cells harbouring activating mutations in the RAS-RAF-MEK pathway
产品资料